{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:58:07Z","timestamp":1792400287158,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.healun.2021.10.013","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:00:43Z","timestamp":1635451243000},"page":"411-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-6236","authenticated-orcid":false,"given":"Raymond L.","family":"Benza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6246-5557","authenticated-orcid":false,"given":"Ath\u00e9na\u00efs","family":"Boucly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaani E.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein-Ardeschir","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius M.","family":"Hoeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lambelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bansilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-2656","authenticated-orcid":false,"given":"Sylvia","family":"Nikkho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-1951","authenticated-orcid":false,"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.10.013_bib0001","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.013_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-019-0950-y","article-title":"The use of risk assessment tools and prognostic scores in managing patients with pulmonary arterial hypertension","volume":"21","author":"Kanwar","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.healun.2021.10.013_bib0003","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.013_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.013_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.013_bib0006","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","article-title":"A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","volume":"39","author":"Kylhammar","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2021.10.013_bib0007","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.10.013_bib0008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.healun.2021.10.013_bib0009","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from REVEAL","volume":"142","author":"Benza","year":"2012","journal-title":"Chest."},{"key":"10.1016\/j.healun.2021.10.013_bib0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.healun.2017.11.006","article-title":"REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival","volume":"37","author":"Benza","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.10.013_bib0011","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.healun.2014.09.016","article-title":"Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis","volume":"34","author":"Benza","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.10.013_bib0012","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","article-title":"Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension","volume":"159","author":"Benza","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.healun.2021.10.013_bib0013","unstructured":"Bayer AG. Adempas (riociguat tablets). EU summary of product characteristics 2019. Accessed March 26, 2020. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/adempas-epar-product-information_en.pdf."},{"key":"10.1016\/j.healun.2021.10.013_bib0014","unstructured":"Bayer AG. Adempas. US prescribing information 2018. Accessed November 24, 2021. http:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Adempas_PI.pdf."},{"key":"10.1016\/j.healun.2021.10.013_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.10.013_bib0016","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.10.013_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2021.03.034","article-title":"Application of the REVEAL risk score calculator 2.0 in the PATENT study","volume":"332","author":"Benza","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2021.10.013_bib0018","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00090614","article-title":"Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)","volume":"45","author":"Rubin","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.013_bib0019","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-2600(16)30019-4","article-title":"Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial","volume":"4","author":"Ghofrani","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2021.10.013_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02004-2018","article-title":"Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.013_bib0021","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s12325-019-01030-4","article-title":"Assessment of risk of disease progression in pulmonary arterial hypertension: insights from an international survey of clinical practice","volume":"36","author":"Simons","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.healun.2021.10.013_bib0022","first-page":"A2512","article-title":"Comparison of risk discrimination between the REVEAL 2.0 calculators, the French pulmonary registry algorithm, and the Bologna method in patients with pulmonary arterial hypertension","volume":"199","author":"Benza","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2021.10.013_bib0023","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00008-2020","article-title":"Risk stratification in pulmonary arterial hypertension using Bayesian analysis","volume":"56","author":"Kanwar","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.10.013_bib0024","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1183\/09031936.00004414","article-title":"Validation of two predictive models for survival in pulmonary arterial hypertension","volume":"46","author":"Sitbon","year":"2015","journal-title":"Eur Respir J"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821025729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821025729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:42:07Z","timestamp":1760949727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821025729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1053249821025729"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.10.013","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}